GPR17 and Myocardial fibrosis: Whether selective modulation of GPR17 signalling in cardiac-resident stromal cells translates into beneficial treatments to reduce the extent of myocardial fibrosis and to limit the functional consequences of heart ischaemia is still a matter of speculation, and it is the subject of our current analyses.